TP53 and KRAS2 mutations in plasma DNA of healthy subjects and subsequent cancer occurrence: a prospective study.

Translated title of the contribution: TP53 and KRAS2 mutations in plasma DNA of healthy subjects and subsequent cancer occurrence: a prospective study.

E. Gormally, P. Vineis, G. Matullo, F. Veglia, E. Caboux, E. Le Roux, M. Peluso, S. Garte, S. Guarrera, A. Munnia, L. Airoldi, H. Autrup, C. Malaveille, A. Dunning, K. Overvad, A. Tjonneland, E. Lund, F. Clavel-Chapelon, H.H. Boeing, A. TrichopoulouD. Palli, V. Krogh, R. Tumino, S. Panico, H.B. Bueno de Mesquita, P.H.M. Peeters, G. Pera, C. Martinez, M. Dorronsoro, A. Barricarte, C. Navarro, J.R. Quiros, G. Hallmans, N.E. Day, T.J. Key, R. Saracci, R. Kaaks, E. Riboli, P. Hainaut

Research output: Contribution to journalArticleAcademicpeer-review

Translated title of the contributionTP53 and KRAS2 mutations in plasma DNA of healthy subjects and subsequent cancer occurrence: a prospective study.
Original languageUndefined/Unknown
Pages (from-to)6871-6876
Number of pages6
JournalCancer Research
Volume66
Issue number13
Publication statusPublished - 2006

Cite this